USANA Health Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION - Schedule of Segment Reporting Information, by Operating Segment (Details)

SEGMENT INFORMATION - Schedule of Segment Reporting Information, by Operating Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 28, 2025	Jun. 29, 2024	Jun. 28, 2025	Jun. 29, 2024
Segment Information [Line Items]
Depreciation and amortization	$ 7,743	$ 3,813	$ 16,082	$ 6,971
Brand Partner incentives	87,040	90,371	177,025	186,129
Direct selling
Segment Information [Line Items]
Depreciation and amortization	2,949	3,457	6,469	6,256
Hiya direct-to-consumer
Segment Information [Line Items]
Depreciation and amortization	4,468	0	8,951	0
Other
Segment Information [Line Items]
Depreciation and amortization	326	356	662	715
Operating Segments
Segment Information [Line Items]
Brand Partner incentives	87,040	90,371	177,025	186,129
Operating Segments \| Direct selling
Segment Information [Line Items]
Brand Partner incentives	86,925	90,239	176,768	185,796
Operating Segments \| Hiya direct-to-consumer
Segment Information [Line Items]
Brand Partner incentives	0		0
Operating Segments \| Other
Segment Information [Line Items]
Brand Partner incentives	$ 115	$ 132	$ 257	$ 333

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References + Details